Chris Freise, MD
I serve as the UCSF director of A2ALL, an NIDDK-sponsored multi-center, longitudinal effort to define the optimum indications and long-term safety and efficacy of living donor liver transplantation. The objective of this work is to contribute to a core database of health information on both donors and recipients obtained pre-operatively, intra-operatively and post-transplant. The collection provides an opportunity to address a number of collaborative research questions relevant to both donors and recipients, such as the development of procedures to optimize intraoperative treatment of the organ donors and identification of factors that predict the recurrence of hepatitis C in recipients of living donor transplants.
Kulik LM, Fisher RA, Rodrigo DR, Brown Jr RS, Freise CE, Shaked A, Everhart JE, Everson GT, Hong JC, Hayashi PH, Berg CL, Lok AS; the A2ALL Study Group. Outcomes of Living and Deceased Donor Liver Transplant Recipients With Hepatocellular Carcinoma: Results of the A2ALL Cohort(†). Am J Transplant. 2012 Nov;12(11):2997-3007.
Abecassis MM, Fisher RA, Olthoff KM, Freise CE, Rodrigo DR, Samstein B, Kam I, Merion RM; A2ALL Study Group. Complications of living donor hepatic lobectomy--a comprehensive report. Am J Transplant. 2012 May;12(5):1208-17.
Vagefi PA, Ascher NL, Freise CE, Dodge JL, Roberts JP. Use of living donor liver transplantation varies with the availability of deceased donor liver transplantation. Liver Transpl. 2012 Feb;18(2):160-5.
Vagefi PA, Parekh J, Ascher NL, Roberts JP, Freise CE. Outcomes with split liver transplantation in 106 recipients: the University of California, San Francisco, experience from 1993 to 2010. Arch Surg. 2011 Sep;146(9):1052-9.
- Professor of Surgery
- Surgery/Transplant Surgery
- Liver Injury and Repair
- Phone: (415) 353-4043
- Phone: (415) 353-1898
- Fax: (415) 353-8709
- 505 Parnassus Ave.
- Box 0780, M-896
- University of California, San Francisco
- San Francisco, CA. 94143-0780